Breakthrough on Curing Liver Cirrhosis by Antithyroid Drug
Two University of Toronto pharmacology professors Dr. Vedy Israel and Dr. Harold Kalant, tied to the Alcohol Research Foundation, announced a major advance in treating cirrhosis. They report propylthiouracil slows accelerated liver metabolism in heavy drinkers.
MENTIONED IN THIS ARTICLE
Toronto
UPI
Vedy Israel
Harold Kalant
University of Toronto
Alcohol Research Foundation
North America
Canada
Israel
Kalant
The
David Archibald
Students paid to get stone to study brain effects
Washington researchers pay a small group of University of Maryland students $25 daily to smoke marijuana for brain impact studies at St Elizabeths Hospital funded by NIMH and NIDA. Dr. Richard Wyatt notes state dependent learning may have strong implications for risk communication.
MENTIONED IN THIS ARTICLE
Wyatt
Antidote treatment offers hope for lymph cancers
A poison followed by its antidote shows promise against lymphosarcoma and reticulosarcoma in 12 children treated at Mercy Catholic Medical Center. Six survived 4.5 to 8 years post diagnosis, a dramatic improvement over typical 70 to 84 percent mortality. Researchers urge careful use by experienced doctors and plan combining with other drugs.
MENTIONED IN THIS ARTICLE
San Diego
Isaac Djerassi
Mercy Catholic Medical Center
Darby
American Cancer Society
Djerassi
Society
Frank Rauscher
National Cancer Institute
Also Mentioned on This Page
Carol Behles
Milton Barnes
San Francisco
William Nickerson
Albert Lowry
Guera Park
Woliday
Mod Beach
Freeway
Santa Ana
Buena Park
Costa Mesa
Bristol St
Newport
Lakewood Blvd
L.B. Airport
Sheraton Amanein Hotel
Bali Road
Disneyland
Anaheim
Nickerson
Alpert Lowry
Roger Larson
Foster Hibbard
Edward Kennedy
D-Mass
New York
Samuel Milham
Washington State
Vancouver
Spaceship
U.S
C._A.B
Echarles
Fprost
American Express
Los Angeles
Air
Western Airlines
Hawaii
Alaska
Western
USA
Mexico
Ocean Blvd